FAKTOR-OPTIONSSCHEIN - APTARGROUP Stock

Certificat

DE000MC2RQS9

Market Closed - Börse Stuttgart 03:12:29 2024-05-17 pm EDT
10.08 EUR +0.80% Intraday chart for FAKTOR-OPTIONSSCHEIN - APTARGROUP
Current month+2.75%
1 month+11.63%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 10.08 +0.80%
24-05-16 10 +0.10%
24-05-15 9.99 -0.99%
24-05-14 10.09 -0.69%
24-05-13 10.16 -1.07%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 03:12 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying APTARGROUP, INC.
Issuer Morgan Stanley
WKN MC2RQS
ISINDE000MC2RQS9
Date issued 2019-07-17
Strike 73.78 $
Maturity Unlimited
Parity 6.78 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.14
Lowest since issue 3.89
Spread 0.05
Spread %0.50%

Company Profile

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
Sector
-
More about the company

Ratings for AptarGroup, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: AptarGroup, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
147.7 USD
Average target price
155 USD
Spread / Average Target
+4.96%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW